TITLE:
A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection

CONDITION:
HIV Infections

INTERVENTION:
Interferon alfa-2b

SUMMARY:

      To study the effectiveness of alpha interferon (IFN-A2b) and zidovudine (AZT) in treating
      progressive multifocal leukoencephalopathy (PML) as a complication of HIV-1 infection.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        Inclusion Criteria

        Patients must have:

          -  HIV seropositivity by both ELISA and Western blot.

          -  Biopsy proven progressive multifocal leukoencephalopathy (PML).

        Exclusion Criteria

        Co-existing Condition:

        Patients with the following conditions or symptoms are excluded:

          -  Intolerant to interferon.

          -  Prior or concomitant central nervous system disease (CNS) such as toxoplasmosis,
             multiple sclerosis (MS), or neurosyphilis.

        Patients with the following are excluded:

          -  Intolerant to interferon.

          -  Prior or concomitant central nervous system disease (CNS) such as toxoplasmosis,
             multiple sclerosis (MS), or neurosyphilis.

        Prior Medication:

        Excluded:

          -  Patients receiving interferon for other reasons.
      
